July 10, 2019
La Jolla — The Salk Institute will celebrate 24 years of Symphony at Salk, its annual concert under the stars, with the sounds of Tony Award-winner Laura Benanti and the acclaimed San Diego Symphony on Saturday, August 24.
Photo Credit: Jenny Anderson
The gala evening concert will showcase Benanti, a five-time Tony Award nominee, singer and stage and screen actress. Currently starring as Eliza Doolittle in Lincoln’s Center’s revival of My Fair Lady, Benanti won the 2008 Tony Award for Outstanding Featured Actress in a Musical for her portrayal of Rose Lee in the Broadway revival of Gypsy.
“It’s my pleasure to take part in this magical evening that will benefit Salk’s world-renowned research into biology and disease,” Benanti says. “It’s an honor to perform under the stars on the Institute’s historic grounds with the lauded San Diego Symphony.”
Individual tickets for Symphony at Salk are $450 and include a champagne reception and gourmet dinner along with immersive entertainment set in the ambiance of the Louis Kahn-designed architectural landmark overlooking the Pacific.
All proceeds support the Salk Institute’s wide-ranging scientific inquiries, which have yielded more than 50 years of life-changing discoveries, as well as Salk’s award-winning educational outreach program, which has helped generations of students discover their passion for research and explore careers in science.
Tickets are on sale now and can be purchased at www.salk.edu/symphony. For more information, call 858-597-0657.
Büro für Kommunikation
Telefon: (858) 453-4100
press@salk.edu
Das Salk Institute ist ein unabhängiges, gemeinnütziges Forschungsinstitut, das 1960 von Jonas Salk, dem Entwickler des ersten sicheren und wirksamen Polio-Impfstoffs, gegründet wurde. Die Aufgabe des Instituts besteht darin, grundlegende, kooperative und risikofreudige Forschung voranzutreiben, die sich mit den dringendsten Herausforderungen der Gesellschaft befasst, darunter Krebs, Alzheimer und die Gefährdung der Landwirtschaft. Diese Grundlagenforschung bildet die Basis für alle translationalen Bemühungen und führt zu Erkenntnissen, die neue Medikamente und Innovationen weltweit ermöglichen.
